伊布替尼治疗慢性淋巴细胞白血病期间发生的非典型原发性皮肤隐球菌病。 - Suppr

Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia.

作者信息

Peri Anna Maria, Rossio Raffaella, Tafuri Francesco, Benzecry Valentina, Grancini Anna, Reda Gianluigi, Bandera Alessandra, Peyvandi Flora

机构信息

Infectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Via Francesco Sforza 32, Milan, Italy.

UOC Medicina Generale - Emostasi e Trombosi, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

出版信息

Ann Hematol. 2019 Dec;98(12):2847-2849. doi: 10.1007/s00277-019-03837-1. Epub 2019 Nov 18.

DOI:10.1007/s00277-019-03837-1

PMID:31741032

Abstract

摘要

相似文献

Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia.

Ann Hematol. 2019 Dec;98(12):2847-2849. doi: 10.1007/s00277-019-03837-1. Epub 2019 Nov 18.

Probable Invasive Pulmonary Cryptococcosis and Possible Cryptococcal Empyema in CLL Treated With Frontline Ibrutinib.

Mayo Clin Proc. 2019 May;94(5):915-917. doi: 10.1016/j.mayocp.2019.02.002.

Ibrutinib-based therapy impaired neutrophils microbicidal activity in patients with chronic lymphocytic leukemia during the early phases of treatment.

Leuk Res. 2019 Dec;87:106233. doi: 10.1016/j.leukres.2019.106233. Epub 2019 Oct 3.

The HELIOS trial protocol: a phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia.

Future Oncol. 2015;11(1):51-9. doi: 10.2217/fon.14.119.

Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.

Drugs Aging. 2017 Jul;34(7):509-527. doi: 10.1007/s40266-017-0468-4.

A case of chronic lymphocytic leukemia complicated by autoimmune hemolytic anemia due to ibrutinib treatment.

J Clin Exp Hematop. 2018 Sep 19;58(3):136-140. doi: 10.3960/jslrt.18012. Epub 2018 Jul 14.

Is ibrutinib associated with disseminated cryptococcosis with CNS involvement?

Cancer Biol Ther. 2019;20(2):138-140. doi: 10.1080/15384047.2018.1508622. Epub 2018 Aug 27.

Emergence of Bruton's tyrosine kinase-negative Hodgkin lymphoma during ibrutinib treatment of chronic lymphocytic leukaemia.

Eur J Haematol. 2017 Oct;99(4):378-380. doi: 10.1111/ejh.12911. Epub 2017 Jul 5.

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.

Lancet Oncol. 2016 Feb;17(2):200-211. doi: 10.1016/S1470-2045(15)00465-9. Epub 2015 Dec 5.

Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL).

Expert Opin Investig Drugs. 2018 Jan;27(1):31-42. doi: 10.1080/13543784.2018.1404027. Epub 2017 Nov 15.

引用本文的文献

Cryptococcosis Associated With Biologic Therapy: A Narrative Review.

Open Forum Infect Dis. 2024 Jun 26;11(7):ofae316. doi: 10.1093/ofid/ofae316. eCollection 2024 Jul.

Mediastinal Small Cell Carcinoma with Primary Cutaneous Cryptococcosis: A Rare Case Report.

Infect Drug Resist. 2021 Sep 9;14:3693-3697. doi: 10.2147/IDR.S325826. eCollection 2021.

Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.

Cancers (Basel). 2021 Jun 29;13(13):3240. doi: 10.3390/cancers13133240.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia.

作者信息

Peri Anna Maria, Rossio Raffaella, Tafuri Francesco, Benzecry Valentina, Grancini Anna, Reda Gianluigi, Bandera Alessandra, Peyvandi Flora

机构信息

Infectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Via Francesco Sforza 32, Milan, Italy.

UOC Medicina Generale - Emostasi e Trombosi, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

出版信息

Ann Hematol. 2019 Dec;98(12):2847-2849. doi: 10.1007/s00277-019-03837-1. Epub 2019 Nov 18.

DOI:10.1007/s00277-019-03837-1

PMID:31741032

Abstract

摘要

相似文献

Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia.

Ann Hematol. 2019 Dec;98(12):2847-2849. doi: 10.1007/s00277-019-03837-1. Epub 2019 Nov 18.

Probable Invasive Pulmonary Cryptococcosis and Possible Cryptococcal Empyema in CLL Treated With Frontline Ibrutinib.

Mayo Clin Proc. 2019 May;94(5):915-917. doi: 10.1016/j.mayocp.2019.02.002.

Ibrutinib-based therapy impaired neutrophils microbicidal activity in patients with chronic lymphocytic leukemia during the early phases of treatment.

Leuk Res. 2019 Dec;87:106233. doi: 10.1016/j.leukres.2019.106233. Epub 2019 Oct 3.

The HELIOS trial protocol: a phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia.

Future Oncol. 2015;11(1):51-9. doi: 10.2217/fon.14.119.

Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.

Drugs Aging. 2017 Jul;34(7):509-527. doi: 10.1007/s40266-017-0468-4.

A case of chronic lymphocytic leukemia complicated by autoimmune hemolytic anemia due to ibrutinib treatment.

J Clin Exp Hematop. 2018 Sep 19;58(3):136-140. doi: 10.3960/jslrt.18012. Epub 2018 Jul 14.

Is ibrutinib associated with disseminated cryptococcosis with CNS involvement?

Cancer Biol Ther. 2019;20(2):138-140. doi: 10.1080/15384047.2018.1508622. Epub 2018 Aug 27.

Emergence of Bruton's tyrosine kinase-negative Hodgkin lymphoma during ibrutinib treatment of chronic lymphocytic leukaemia.

Eur J Haematol. 2017 Oct;99(4):378-380. doi: 10.1111/ejh.12911. Epub 2017 Jul 5.

Lancet Oncol. 2016 Feb;17(2):200-211. doi: 10.1016/S1470-2045(15)00465-9. Epub 2015 Dec 5.

Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL).

Expert Opin Investig Drugs. 2018 Jan;27(1):31-42. doi: 10.1080/13543784.2018.1404027. Epub 2017 Nov 15.

引用本文的文献

Cryptococcosis Associated With Biologic Therapy: A Narrative Review.

Open Forum Infect Dis. 2024 Jun 26;11(7):ofae316. doi: 10.1093/ofid/ofae316. eCollection 2024 Jul.

Mediastinal Small Cell Carcinoma with Primary Cutaneous Cryptococcosis: A Rare Case Report.

Infect Drug Resist. 2021 Sep 9;14:3693-3697. doi: 10.2147/IDR.S325826. eCollection 2021.

Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.

Cancers (Basel). 2021 Jun 29;13(13):3240. doi: 10.3390/cancers13133240.

Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献